Ritesh Parekh
Ritesh Parekh is currently Vice President of Market Access and Channel Strategy for the US Business Unit at Takeda Pharmaceuticals. His team is responsible for payer, pricing, channel and reimbursement strategy across all products within the US Business Unit, including retail, specialty and rare therapies. His scope includes in-line, pipeline and business development assets, with a focus on ensuring patients have access to Takeda’s current and future medicines.
Ritesh has been developing market access strategies for the last 10 years, launching and supporting multiple products within the specialty and rare disease categories. Prior to specializing in market access, Ritesh served in various global and US commercial roles, including prescriber and patient marketing. Ritesh was also a consultant with Deloitte, working across numerous industries, with a concentration on large health systems.
Ritesh graduated from the University of Illinois Champaign-Urbana with a degree in Computer Engineering, and a minor in Technology and Management. Ritesh later completed his MBA from Kellogg School of Management (Northwestern University). He lives with his wife and three daughters in the suburbs of Chicago.
Full-Time / Evening & Weekend MBA Courses
Pharmaceutical Strategy (HCAK-931-0)
The healthcare industry is not only highly regulated but also has multiple stakeholders. From policymakers such as FDA to payers, from providers to insurers, from physician researchers to patient advocacy groups, there is a rich variety of partners that calls for collaborative approaches and behaviors. This means that pharmaceutical leaders must not only acquire drug development expertise, but also become highly skilled in navigating the regulatory framework and managing multi-stakeholder networks. This course will provide contextual guidance and help leaders broaden their personal repertoire and toolbox to succeed with developing a comprehensive pharmaceutical strategy. The objective of this Pharmaceutical Strategy course is to build on the existing Healthcare Strategy to equip participants with a deep knowledge around drug commercialization so they can thrive in what is a hyper-complex healthcare, scientific and socioeconomic environment. A basic understanding of the health care industry is suggested but not required. Please note: STRT-443 Healthcare Strategy OR STRT-444 Healthcare Economics are STRONGLY recommended prerequisites for the class .
Pharmaceutical Strategy (HCAK-931-0)
The healthcare industry is not only highly regulated but also has multiple stakeholders. From policymakers such as FDA to payers, from providers to insurers, from physician researchers to patient advocacy groups, there is a rich variety of partners that calls for collaborative approaches and behaviors. This means that pharmaceutical leaders must not only acquire drug development expertise, but also become highly skilled in navigating the regulatory framework and managing multi-stakeholder networks. This course will provide contextual guidance and help leaders broaden their personal repertoire and toolbox to succeed with developing a comprehensive pharmaceutical strategy. The objective of this Pharmaceutical Strategy course is to build on the existing Healthcare Strategy to equip participants with a deep knowledge around drug commercialization so they can thrive in what is a hyper-complex healthcare, scientific and socioeconomic environment. A basic understanding of the health care industry is suggested but not required. Please note: STRT-443 Healthcare Strategy OR STRT-444 Healthcare Economics are STRONGLY recommended prerequisites for the class .
